Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies

被引：1
|
作者：
Meringa, A. D. [1 ]
Hernandez-Lopez, P. [1 ]
Cleven, A. [1 ]
de Witte, M. [1 ,2 ]
Straetemans, T. [1 ,2 ]
Kuball, J. [1 ,2 ]
Beringer, D. X. [1 ]
Sebestyen, Z. [1 ]
机构：
[1] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词：
T-cell therapy; gamma delta TCR; cancer; immune therapy; antigen; fitness; TME (tumor microenvironment); migration; ANTIGEN RECEPTOR; ANTITUMOR-ACTIVITY; 4-1BB COSTIMULATION; RECOGNITION; LYMPHOCYTES; TUMORS; STRESS; MICROENVIRONMENT; IMMUNOTHERAPY; CYTOKINE;
D O I：
10.3389/fimmu.2023.1159337
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [41] The role of T-cell phenotype and T-cell receptor rearrangement in the diagnosis of T-cell malignancies
    Sorigue, Marc
    Junca, Jordi
    Marce, Silvia
    Cabezon, Marta
    Garcia, Olga
    Zamora, Lurdes
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 244 - 246
  • [42] T-cell therapies for HIV
    Lam, Sharon
    Bollard, Catherine
    IMMUNOTHERAPY, 2013, 5 (04) : 407 - 414
  • [43] ENGINEERED T-CELL TREATMENT IN THE AREA OF ACUTE LYMPHOBLASTIC LEUKEMIA
    Saglio, Francesco
    LEUKEMIA RESEARCH, 2015, 39 : SS11 - SS11
  • [44] Advances in Chimeric Antigen Receptor T-Cell Therapies for Solid Tumors
    Baybutt, Trevor R.
    Flickinger, John C., Jr.
    Caparosa, Ellen M.
    Snook, Adam E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) : 71 - 78
  • [45] Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy
    Parvathaneni, Kalpana
    Abdeladhim, Maha
    Pratt, Kathleen P.
    Scott, David W.
    TRANSLATIONAL RESEARCH, 2017, 187 : 44 - 52
  • [46] Clinical management of T-Cell malignancies: Current perspectives, key issues, and emerging therapies
    Cheson, Bruce D.
    SEMINARS IN ONCOLOGY, 2007, 34 (06) : S3 - S7
  • [47] Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies
    Arunachalam, Arun K.
    Gregoire, Celine
    de Oliveira, Beatriz Coutinho
    Melenhorst, Jan Joseph
    BLOOD REVIEWS, 2024, 68
  • [48] T-CELL MALIGNANCIES AND HUMAN T-CELL LEUKEMIA-VIRUS
    GALLO, RC
    SARIN, PS
    BLATTNER, WA
    WONGSTAAL, F
    POPOVIC, M
    SEMINARS IN ONCOLOGY, 1984, 11 (01) : 12 - 17
  • [49] Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential
    Chamorro, Diego F.
    Somes, Lauren K.
    Hoyos, Valentina
    CANCERS, 2024, 16 (01)
  • [50] Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals
    Huisman, Wesley
    Hageman, Lois
    Leboux, Didier A. T.
    Khmelevskaya, Alexandra
    Efimov, Grigory A.
    Roex, Marthe C. J.
    Amsen, Derk
    Falkenburg, J. H. Frederik
    Jedema, Inge
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345